SIGMA LABS, INC.·4

Aug 13, 7:00 PM ET

Orzechowski Frank 4

4 · SIGMA LABS, INC. · Filed Aug 13, 2021

Insider Transaction Report

Form 4
Period: 2021-08-11
Orzechowski Frank
CFO, PFO and PAO
Transactions
  • Award

    Stock Option (right to buy)

    2021-08-11+48,58048,580 total
    Exercise: $3.42Exp: 2026-08-11Common Stock (48,580 underlying)
  • Award

    Stock Appreciation Right

    2021-08-11+48,58048,580 total
    Exercise: $3.42Exp: 2026-08-11Common Stock (48,580 underlying)
Footnotes (2)
  • [F1]The stock option will vest and become exercisable as follows: (i) 25% of the option vested on the grant date (i.e., August 11, 2021), and (ii) the balance of the option will vest in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.
  • [F2]The stock appreciation right ("SAR") is payable in cash only, and vests as follows: (i) 25% of the SAR vested on the grant date (i.e., August 11, 2021), and (ii) the balance of the SAR will vest in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary